FEATURED ARTICLE
KACTUS GMP-Grade Cas9 Enzyme supports manufacturing and FDA clearance of UCAR-T cell therapy drug products
KACTUS is excited to share that our GMP-Grade Cas9 enzyme is serving as a critical manufacturing raw material for an investigational new drug (IND) developed by Bioheng Therapeutics. Bioheng’s innovative UCART cell product received IND clearance by the U.S. Food and Drug Administration (FDA) on March 1, 2025 [1]. This approval marks...
KACTUS GMP-Grade Cas9 Enzyme supports manufacturing and FDA clearance of UCAR-T cell therapy drug products
KACTUS is excited to share that our GMP-Grade Cas9 enzyme is serving as a critical manufacturing raw material for an investigational new drug (IND) developed by Bioheng Therapeutics. Bioheng’s innovative UCART cell product received IND clearance by the U.S. Food and Drug Administration (FDA) on March 1, 2025 [1]. This approval marks...
